$ETON News

Eton Pharma Enters Into Supply And Distribution Agreement For US Commercialization Rights To IMPAVIDO From Affiliate Of Knight Therapeutics

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $57

Eton Pharmaceuticals Inc (ETON) Q1 2026 Earnings Call Highlights: Record Sales and Strategic ...

Eton Pharmaceuticals Q1 Earnings Call Highlights

Eton Pharmaceuticals, Inc. (ETON) Misses Q1 Earnings Estimates

Eton Pharmaceuticals, Inc. (ETON) Q1 2026 Earnings Call Transcript

Eton Pharmaceuticals (NASDAQ:ETON) Soars on Q1 Beat, Raises Full-Year Guidance

Eton Pharmaceuticals Reports First Quarter 2026 Financial Results

Full Transcript: Eton Pharmaceuticals Q1 2026 Earnings Call

Eton Pharmaceuticals FY2026 Revenue expected to be more than $120.000M vs $113.804M Est

Eton Pharmaceuticals Q1 Adj. EPS $0.14 Beats $0.09 Estimate, Sales $24.266M Beat $22.312M Estimate

Eton Pharmaceuticals to Participate in Upcoming Investor Conferences

Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates

Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Lags Revenue Estimates

Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026

How The Hemangeol Deal Is Rewriting The Story For Eton Pharmaceuticals (ETON)

Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution

Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700

Eton Pharma Announces First Patient Dosed In Pilot Clinical Study Assessing Efficacy Of ET-700 For Treatment Of Wilson Disease; Topline Study Results Expected In H2 2026

Eton Pharmaceuticals (ETON) Appoints Judith M. Matthews as New CFO